At a glance
- Originator Aventis
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections; HIV infections
Most Recent Events
- 01 Sep 1998 No-Development-Reported for Herpes simplex virus infections in USA (Unknown route)
- 01 Sep 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 01 Feb 1995 Preclinical development for Herpes simplex virus infections in USA (Unknown route)